ARCHIVES

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: New Arizona Cancer Center Building Dedicated; Free Copies Of FY 1988 Bypass Budget Available

November 7, 1986

Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects

August 29, 2008

In Brief: Columbia University Double Lab Space; GM Cancer Awards to Suit, Folkman, Nurse

June 6, 1997

Minimally Invasive Radiation Said To Preserve Functions

April 24, 2009

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

May 8, 2013

Judge Rules First Amendment Protects Distribution Of Off-Label Use Information

August 14, 1998